Neomycin-OVA

• Description :

  Neomycin-OVA is a conjugate of Neomycin (HY-150520) and Ovalbumin (OVA) . By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].

• UNSPSC :

  12352100

• Target :

  Biochemical Assay Reagents

• Related Pathways :

  Others

• Field of Research :

  Inflammation/Immunology

• Smiles :

  [Neomycin-OVA]

• References & Citations :

  [1]Liu Y, et al. Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine. J Vet Pharmacol Ther. 2021 Sep;44 (5) :850-853.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Biochemical Assay Reagents

• Clinical Information :

  No Development Reported